tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

UTHR Stock Latest News

Notable companies reporting before tomorrow’s open
The FlyNotable companies reporting before tomorrow’s open
16h ago
MO
HOG
Bleecker Street Research short United Therapeutics, long Liquidia
PremiumThe Fly
Bleecker Street Research short United Therapeutics, long Liquidia
20h ago
LQDA
UTHR
United Therapeutics’ Inhaled Treprostinil Study: A Potential Game-Changer for Pulmonary Fibrosis
PremiumCompany Announcements
United Therapeutics’ Inhaled Treprostinil Study: A Potential Game-Changer for Pulmonary Fibrosis
2d ago
UTHR
United Therapeutics’ Promising IPF Treatment Study: A Market Game-Changer?
PremiumCompany Announcements
United Therapeutics’ Promising IPF Treatment Study: A Market Game-Changer?
2d ago
UTHR
United Therapeutics’ Phase 3 Study on Inhaled Treprostinil: A Potential Game-Changer for IPF Treatment
PremiumCompany Announcements
United Therapeutics’ Phase 3 Study on Inhaled Treprostinil: A Potential Game-Changer for IPF Treatment
2d ago
UTHR
United Therapeutics Corp. (UTHR) Q2 Earnings Cheat Sheet
PremiumPre-EarningsUnited Therapeutics Corp. (UTHR) Q2 Earnings Cheat Sheet
2d ago
UTHR
Positive Outlook for United Therapeutics Driven by Tyvaso Growth and IPF Potential
Premium
Ratings
Positive Outlook for United Therapeutics Driven by Tyvaso Growth and IPF Potential
6d ago
UTHR
Optimistic Buy Rating for United Therapeutics Amid Promising Tyvaso Developments in IPF Treatment
Premium
Ratings
Optimistic Buy Rating for United Therapeutics Amid Promising Tyvaso Developments in IPF Treatment
15d ago
UTHR
Oppenheimer bullish on United Therapeutics, sees grand upside from TETON readout
PremiumThe Fly
Oppenheimer bullish on United Therapeutics, sees grand upside from TETON readout
16d ago
UTHR
United Therapeutics’ Phase 3 Study on Inhaled Treprostinil: A Potential Game-Changer for Pulmonary Fibrosis
PremiumCompany Announcements
United Therapeutics’ Phase 3 Study on Inhaled Treprostinil: A Potential Game-Changer for Pulmonary Fibrosis
19d ago
UTHR
United Therapeutics’ DeciPHer-ILD Study: A New Frontier in Pulmonary Hypertension Research
PremiumCompany Announcements
United Therapeutics’ DeciPHer-ILD Study: A New Frontier in Pulmonary Hypertension Research
19d ago
UTHR
United Therapeutics price target lowered to $328 from $348 at Morgan Stanley
PremiumThe Fly
United Therapeutics price target lowered to $328 from $348 at Morgan Stanley
20d ago
UTHR
United Therapeutics’ Phase 3 Study on Inhaled Treprostinil for Pulmonary Fibrosis: Key Insights for Investors
PremiumCompany AnnouncementsUnited Therapeutics’ Phase 3 Study on Inhaled Treprostinil for Pulmonary Fibrosis: Key Insights for Investors
21d ago
UTHR
United Therapeutics price target lowered to $330 from $350 at JPMorgan
Premium
The Fly
United Therapeutics price target lowered to $330 from $350 at JPMorgan
22d ago
UTHR
United Therapeutics’ Inhaled Treprostinil Study: A Potential Game-Changer for IPF Treatment
Premium
Company Announcements
United Therapeutics’ Inhaled Treprostinil Study: A Potential Game-Changer for IPF Treatment
30d ago
UTHR
United Therapeutics’ Promising Study on Inhaled Treprostinil for Pulmonary Fibrosis
PremiumCompany Announcements
United Therapeutics’ Promising Study on Inhaled Treprostinil for Pulmonary Fibrosis
30d ago
UTHR
United Therapeutics price target lowered to $385 from $410 at UBS
PremiumThe Fly
United Therapeutics price target lowered to $385 from $410 at UBS
30d ago
UTHR
Liquidia price target lowered to $40 from $45 at BTIG
PremiumThe Fly
Liquidia price target lowered to $40 from $45 at BTIG
1M ago
LQDA
UTHR
United Therapeutics Shareholders Approve Key Resolutions
PremiumCompany Announcements
United Therapeutics Shareholders Approve Key Resolutions
1M ago
8K
UTHR
United Therapeutics’ Ralinepag Study: A Potential Game-Changer in PAH Treatment
PremiumCompany AnnouncementsUnited Therapeutics’ Ralinepag Study: A Potential Game-Changer in PAH Treatment
1M ago
UTHR
United Therapeutics: Pioneering Organ Manufacturing and Strategic Growth with miroliverELAP
Premium
Ratings
United Therapeutics: Pioneering Organ Manufacturing and Strategic Growth with miroliverELAP
1M ago
UTHR
United Therapeutics’ Ralinepag Study: A Potential Game-Changer for PAH Treatment
Premium
Company Announcements
United Therapeutics’ Ralinepag Study: A Potential Game-Changer for PAH Treatment
1M ago
UTHR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >